Financial Information

This section houses up-to-date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing.

Please note: All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes. Sera Prognostics assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQSERA
Beta1.49
Shares Outstanding32.4M
Average Volume (10 days)103.4K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($1.22)
Sales (TTM)$0.01
Book Value (MRQ)$2.16
Cash Flow (TTM)($0.84)
Cash (MRQ)$1.56

Analyst Views

Current Mean RecommendationBuy
Strong Buy2
 
Buy0
 
Hold1
 
Underperform0
 
Sell0
 

Recent Insider Transactions

John J. Boniface
Chief Scientific Officer
(24,474)
Sell
Mar 28, 2024
John J. Boniface
Chief Scientific Officer
(3,753)
Sell
Mar 27, 2024
John J. Boniface
Chief Scientific Officer
(48,909)
Sell
Mar 27, 2024
Austin Aerts
Chief Financial Officer
(8,092)
Sell
Mar 26, 2024
John J. Boniface
Chief Scientific Officer
(21,438)
Sell
Mar 26, 2024

Recent SEC Filings

Annual Report
Apr 23, 2024
Proxy Statement
Apr 23, 2024
DEFA14A
Apr 23, 2024
>= 5% Acquisition
Apr 1, 2024
Insider Buy/Sell
Mar 28, 2024

Email Alerts

Sign up for our investor relations email list here.